Inflammasome-Dependent Induction of Adaptive NK Cell Memory

Immunity

Volumn 44, Issue 6, 2016, Pages 1406-1421

  van den Boorn, Jasper G ^a   Jakobs, Christopher ^a   Hagen, Christian ^a   Renn, Marcel ^a   Luiten, Rosalie M ^b   Melief, Cornelis J M ^c,d   Tüting, Thomas ^a   Garbi, Natalio ^a   Hartmann, Gunther ^a   Hornung, Veit ^a,e  

^a UNIVERSITY HOSPITAL BONN   (Germany)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^d ISA Pharmaceuticals   (Netherlands)

^e UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CRYOPYRIN; HAPTEN; INFLAMMASOME; INTERLEUKIN 18; MONOBENZONE; APOPTOSIS REGULATORY PROTEIN; HYDROQUINONE DERIVATIVE; NLRP3 PROTEIN, MOUSE; PYCARD PROTEIN, MOUSE;

ADAPTIVE IMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNITY; CELL INFILTRATION; CONTACT ALLERGY; CONTROLLED STUDY; CYTOTOXICITY; IMMUNE RESPONSE; IMMUNOGENICITY; IMMUNOLOGICAL MEMORY; INFLAMMATION; LIVER; LYMPH NODE; MACROPHAGE; MELANOCYTE; MEMORY CELL; MOUSE; NATURAL KILLER CELL; NONHUMAN; PHENOTYPE; PIGMENT CELL; PRIORITY JOURNAL; PROTEIN FUNCTION; ANIMAL; C57BL MOUSE; CELL CULTURE; CONTACT DERMATITIS; GENETICS; IMMUNOLOGY; KNOCKOUT MOUSE; LYMPHOCYTE ACTIVATION; METABOLISM; PATHOLOGY; PHYSIOLOGY;

ADAPTIVE IMMUNITY; ANIMALS; APOPTOSIS REGULATORY PROTEINS; CELLS, CULTURED; DERMATITIS, CONTACT; HYDROQUINONES; IMMUNOLOGIC MEMORY; INFLAMMASOMES; INTERLEUKIN-18; KILLER CELLS, NATURAL; LIVER; LYMPHOCYTE ACTIVATION; MACROPHAGES; MELANOCYTES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NLR FAMILY, PYRIN DOMAIN-CONTAINING 3 PROTEIN;

EID: 84973541067     PISSN: 10747613     EISSN: 10974180     Source Type: Journal    
DOI: 10.1016/j.immuni.2016.05.008     Document Type: Article

References (43)

1. AlGhamdi K.M., Kumar A. Depigmentation therapies for normal skin in vitiligo universalis. J. Eur. Acad. Dermatol. Venereol. 2011, 25:749-757. 10.1111/j.1468-3083.2010.03876.x.
2. Arase H., Mocarski E.S., Campbell A.E., Hill A.B., Lanier L.L. Direct recognition of cytomegalovirus by activating and inhibitory NK cell receptors. Science 2002, 296:1323-1326. 10.1126/science.1070884.
3. Bain C.C., Scott C.L., Uronen-Hansson H., Gudjonsson S., Jansson O., Grip O., Guilliams M., Malissen B., Agace W.W., Mowat A.M. Resident and pro-inflammatory macrophages in the colon represent alternative context-dependent fates of the same Ly6Chi monocyte precursors. Mucosal Immunol. 2013, 6:498-510. 10.1038/mi.2012.89.
4. Bogunovic M., Ginhoux F., Wagers A., Loubeau M., Isola L.M., Lubrano L., Najfeld V., Phelps R.G., Grosskreutz C., Scigliano E., et al. Identification of a radio-resistant and cycling dermal dendritic cell population in mice and men. J. Exp. Med. 2006, 203:2627-2638. 10.1084/jem.20060667.
5. Catona A., Lanzer D. Monobenzone, Superfade, vitiligo and confetti-like depigmentation. Med. J. Aust. 1987, 146:320-321.
6. Cooper M.A., Elliott J.M., Keyel P.A., Yang L., Carrero J.A., Yokoyama W.M. Cytokine-induced memory-like natural killer cells. Proc. Natl. Acad. Sci. USA 2009, 106:1915-1919. 10.1073/pnas.0813192106.
7. Davies L.C., Jenkins S.J., Allen J.E., Taylor P.R. Tissue-resident macrophages. Nat. Immunol. 2013, 14:986-995. 10.1038/ni.2705.
8. Davies L.C., Rosas M., Jenkins S.J., Liao C.-T., Scurr M.J., Brombacher F., Fraser D.J., Allen J.E., Jones S.A., Taylor P.R. Distinct bone marrow-derived and tissue-resident macrophage lineages proliferate at key stages during inflammation. Nat. Commun. 2013, 4:1886. 10.1038/ncomms2877.
9. Ezzedine K., Eleftheriadou V., Whitton M., van Geel N. Vitiligo. The Lancet. 2015, 386:74-84. 10.1016/S0140-6736(14)60763-7.
10. Forman L. A note on the depigmentary properties of monobenzylether of hydroquinone. Br. J. Dermatol. 1953, 65:406-409.
11. Gad S.C., Dunn B.J., Dobbs D.W., Reilly C., Walsh R.D. Development and validation of an alternative dermal sensitization test: the mouse ear swelling test (MEST). Toxicol. Appl. Pharmacol. 1986, 84:93-114. 10.1016/0041-008X(86)90419-9.
12. Grabbe S., Schwarz T. Immunoregulatory mechanisms involved in elicitation of allergic contact hypersensitivity. Immunol. Today 1998, 19:37-44.
13. Guarda G., Zenger M., Yazdi A.S., Schroder K., Ferrero I., Menu P., Tardivel A., Mattmann C., Tschopp J. Differential Expression of NLRP3 among Hematopoietic Cells. Journal of Immunology 2011, 186:2529-2534. (Baltimore, Md.: 1950). 10.4049/jimmunol.1002720.
14. Kaplan D.H., Igyártó B.Z., Gaspari A.A. Early immune events in the induction of allergic contact dermatitis 2012, Nature Publishing Group. 10.1038/nri3150.
15. Landsberg J., Kohlmeyer J., Renn M., Bald T., Rogava M., Cron M., Fatho M., Lennerz V., Wölfel T., Hölzel M., Tüting T. Melanomas resist T-cell therapy through inflammation-induced reversible dedifferentiation. Nature 2012, 490:412-416. 10.1038/nature11538.
16. Long E.O., Kim H.S., Liu D., Peterson M.E., Rajagopalan S. Controlling Natural Killer Cell Responses: Integration of Signals for Activation and Inhibition. Annual Reviews of Immunology 2013, 31:227-258.
17. Majewska-Szczepanik M., Paust S., von Andrian U.H., Askenase P.W., Szczepanik M. Natural killer cell-mediated contact sensitivity develops rapidly and depends on interferon-α, interferon-γ and interleukin-12. Immunology 2013, 140:98-110. 10.1111/imm.12120.
18. Mariathasan S., Weiss D.S., Newton K., McBride J., O'Rourke K., Roose-Girma M., Lee W.P., Weinrauch Y., Monack D.M., Dixit V.M. Cryopyrin activates the inflammasome in response to toxins and ATP. Nature 2006, 440:228-232. 10.1038/nature04515.
19. Merad M., Manz M.G., Karsunky H., Wagers A., Peters W., Charo I., Weissman I.L., Cyster J.G., Engleman E.G. Langerhans cells renew in the skin throughout life under steady-state conditions. Nat. Immunol. 2002, 3:1135-1141. 10.1038/ni852.
20. Min-Oo G., Kamimura Y., Hendricks D.W., Nabekura T., Lanier L.L. Natural killer cells: walking three paths down memory lane. Trends Immunol. 2013, 34:251-258. 10.1016/j.it.2013.02.005.
21. Ni J., Miller M., Stojanovic A., Garbi N., Cerwenka A. Sustained effector function of IL-12/15/18-preactivated NK cells against established tumors. J. Exp. Med. 2012, 209:2351-2365. 10.1084/jem.20120944.
22. Nordlund J.J., Forget B., Kirkwood J., Lerner A.B. Dermatitis produced by applications of monobenzone in patients with active vitiligo. Arch. Dermatol. 1985, 121:1141-1144. 10.1001/archderm.1985.01660090055013.
23. O'Leary J.G., Goodarzi M., Drayton D.L., von Andrian U.H. T cell- and B cell-independent adaptive immunity mediated by natural killer cells. Nat. Immunol. 2006, 7:507-516. 10.1038/ni1332.
24. O'Sullivan T., Saddawi-Konefka R., Vermi W., Koebel C.M., Arthur C., White J.M., Uppaluri R., Andrews D.M., Ngiow S.F., Teng M.W.L., et al. Cancer immunoediting by the innate immune system in the absence of adaptive immunity. J. Exp. Med. 2012, 209:1869-1882. 10.1084/jem.20112738.
25. O'Sullivan T.E., Sun J.C., Lanier L.L. Natural Killer Cell Memory. Immunity 2015, 43:634-645. 10.1016/j.immuni.2015.09.013.
26. Perdiguero E.G., Geissmann F. The development and maintenance of resident macrophages. Nat. Immunol. 2016, 17:2-8. 10.1038/ni.3341.
27. Reeves R.K., Li H., Jost S., Blass E., Li H., Schafer J.L., Varner V., Manickam C., Eslamizar L., Altfeld M., von Andrian U.H., Barouch D.H. Antigen-specific NK cell memory in rhesus macaques. Nat. Immunol. 2015, 16:927-932. 10.1038/ni.3227.
28. Romee R., Schneider S.E., Leong J.W., Chase J.M., Keppel C.R., Sullivan R.P., Cooper M.A., Fehniger T.A. Cytokine activation induces human memory-like NK cells. Blood 2012, 120:4751-4760. 10.1182/blood-2012-04-419283.
29. Shinkai Y., Rathbun G., Lam K.P., Oltz E.M., Stewart V., Mendelsohn M., Charron J., Datta M., Young F., Stall A.M., et al. RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement. Cell 1992, 68:855-867.
30. Smith-Garvin J.E., Koretzky G.A., Jordan M.S. T cell activation. Annu. Rev. Immunol. 2009, 27:591-619.
31. Sun J.C., Beilke J.N., Lanier L.L. Adaptive immune features of natural killer cells. Nature 2009, 457:557-561. 10.1038/nature07665.
32. Sutterwala F.S., Ogura Y., Szczepanik M., Lara-Tejero M., Lichtenberger G.S., Grant E.P., Bertin J., Coyle A.J., Galán J.E., Askenase P.W., Flavell R.A. Critical role for NALP3/CIAS1/Cryopyrin in innate and adaptive immunity through its regulation of caspase-1. Immunity 2006, 24:317-327. 10.1016/j.immuni.2006.02.004.
33. Tamoutounour S., Henri S., Lelouard H., de Bovis B., de Haar C., van der Woude C.J., Woltman A.M., Reyal Y., Bonnet D., Sichien D., et al. CD64 distinguishes macrophages from dendritic cells in the gut and reveals the Th1-inducing role of mesenteric lymph node macrophages during colitis. Eur. J. Immunol. 2012, 42:3150-3166. 10.1002/eji.201242847.
34. van den Boorn J.G., Konijnenberg D., Dellemijn T.A.M., van der Veen J.P.W., Bos J.D., Melief C.J.M., Vyth-Dreese F.A., Luiten R.M. Autoimmune Destruction of Skin Melanocytes by Perilesional T Cells from Vitiligo Patients. J Invest Dermatol. 2009, 129:2220-2232. 10.1038/jid.2009.32.
35. van den Boorn J.G., Konijnenberg D., Tjin E.P.M., Picavet D.I., Meeuwenoord N.J., Filippov D.V., van der Veen J.P.W., Bos J.D., Melief C.J.M., Luiten R.M. Effective melanoma immunotherapy in mice by the skin-depigmenting agent monobenzone and the adjuvants imiquimod and CpG. PLoS ONE 2010, 5:e10626. 10.1371/journal.pone.0010626.
36. van den Boorn J.G., Melief C.J., Luiten R.M. Monobenzone-induced depigmentation: from enzymatic blockade to autoimmunity. Pigment Cell Melanoma Res. 2011, 24:673-679. 10.1111/j.1755-148X.2011.00878.x.
37. van den Boorn J.G., Picavet D.I., van Swieten P.F., van Veen H.A., Konijnenberg D., van Veelen P.A., van Capel T., Jong E.C., Reits E.A., Drijfhout J.W., et al. Skin-depigmenting agent monobenzone induces potent T-cell autoimmunity toward pigmented cells by tyrosinase haptenation and melanosome autophagy. J. Invest. Dermatol. 2011, 131:1240-1251. 10.1038/jid.2011.16.
38. Van Kaer L. Innate and virtual memory T cells in man. Eur. J. Immunol. 2015, 45:1916-1920. 10.1002/eji.201545761.
39. Watanabe H., Gaide O., Pétrilli V., Martinon F., Contassot E., Roques S., Kummer J.A., Tschopp J., French L.E. Activation of the IL-1β-processing inflammasome is involved in contact hypersensitivity. J. Invest. Dermatol. 2007, 127:1956-1963. 10.1038/sj.jid.5700819.
40. Weber F.C., Esser P.R., Müller T., Ganesan J., Pellegatti P., Simon M.M., Zeiser R., Idzko M., Jakob T., Martin S.F. Lack of the purinergic receptor P2X(7) results in resistance to contact hypersensitivity. J. Exp. Med. 2010, 207:2609-2619. 10.1084/jem.20092489.
41. Weber B., Saurer L., Schenk M., Dickgreber N., Mueller C. CX3CR1 defines functionally distinct intestinal mononuclear phagocyte subsets which maintain their respective functions during homeostatic and infl... - PubMed - NCBI. Eur. J. Immunol. 2011, 41:773-779. 10.1002/eji.201040965.
42. Yu R., Broady R., Huang Y., Wang Y., Yu J., Gao M., Levings M., Wei S., Zhang S., Xu A., et al. Transcriptome analysis reveals markers of aberrantly activated innate immunity in vitiligo lesional and non-lesional skin. PLoS ONE 2012, 7:e51040. 10.1371/journal.pone.0051040.
43. Zaba L.C., Krueger J.G., Lowes M.A. Resident and "inflammatory" dendritic cells in human skin. J. Invest. Dermatol. 2009, 129:302-308. 10.1038/jid.2008.225.